IXOPAY and Aperia Compliance Merge to Extend Advanced Payment Data Security to Merchant Acquirers and Merchants of All Sizes, Worldwide
Merger combines IXOPAY's enterprise-grade capabilities in payment orchestration and tokenization with Aperia Compliance's PCI DSS Level 3 and 4 solutions.
TULSA, OKLAHOMA / ACCESSWIRE / December 4, 2024 / IXOPAY, a leading payments technology provider handling more than $35 billion in payment volume through its enterprise-grade payment orchestration platform, announced today that it has merged with Aperia Compliance, a subsidiary of Aperia Solutions and a leading firm in Payment Card Industry Data Security Standard (PCI DSS) data validation and risk management. Serving more than 100 merchant acquirers, Aperia Compliance will operate as "Aperia Compliance, an IXOPAY company."
IXOPAY offers enterprise-grade PCI DSS Level 1 and 2 solutions powered by advanced tokenization. Paired with Aperia Compliance's robust PCI DSS Level 3 and 4 solutions-including PCI Apply 4.0 and the new 6.4.3 product-the combined offering aims to deliver a scalable, end-to-end solution enabling merchants, independent sales organizations (ISOs), and payment processors to comply with global data security standards, streamline operations, and drive revenue growth.
"Today's merger with Aperia Compliance enables IXOPAY to extend its capabilities and seeks to provide merchant acquirers of all sizes with powerful tools to navigate updated PCI DSS Version 4.0 requirements and secure their payment systems," said Brady Harris, CEO of IXOPAY. "By combining Aperia Compliance's PCI DSS Level 3 and 4 solutions with our enterprise-grade payments orchestration, we're expanding our platform with the goal of further simplifying compliance, enhancing security, and supporting businesses as they adapt to the evolving payments landscape."
Customers of both companies will now have access to the entire product suite. IXOPAY customers will have access to Aperia Compliance's PCI DSS Level 3 and 4 validation and risk management solutions, which include self-assessment questionnaire assistance, vulnerability scanning, multilingual support, integrated security solutions, data breach protection, merchant education, and reporting and analytics. Aperia Compliance customers-ISOs, processors, banks, and payfacs-gain access to IXOPAY's PCI DSS Level 1 and 2 tokenization and payment orchestration capabilities, along with fraud prevention, automated account updater, 3-D Secure authentication, point-to-point encryption, network token security, and detailed compliance reporting with universal tokens.
"The strategic merger of Aperia Compliance and IXOPAY creates a broader set of tools that enable businesses to compete in the fast-paced payments space," said Kevin Mokarow, Chairman and CEO of Aperia Solutions and senior advisor to the IXOPAY board of directors. "By combining strengths, we're extending IXOPAY's capabilities to small and medium-sized businesses worldwide, aiming to help merchants, ISOs, and processors reduce errors, prevent fraud, and streamline operations for sustainable growth."
The merger with Aperia Compliance is the latest transaction announced by IXOPAY, a portfolio company of K1 Investment Management, following IXOPAY's recent merger with TokenEx and a slate of new executive appointments, including CEO Brady Harris.
"This is another step on the way to creating a payments industry leader," said Tarun Jain, Principal at K1 Investment Management. "Earlier this year, the integration of TokenEx's advanced tokenization technology positioned IXOPAY as a continued innovator in the world of payment data security. With the addition of Aperia Compliance's PCI products, IXOPAY continues to strengthen its platform and help redefine payment operations for businesses worldwide."
Aperia Compliance's management team is continuing with the business under IXOPAY. Aperia Solutions is not a part of the merger and will continue to operate under the Aperia brand.
Media Contact
Mills Forni, Verdis
About IXOPAY
IXOPAY is a leading provider of enterprise-grade payment orchestration, providing a fully integrated platform and flexible payment optimization modules to businesses around the world. With a single API and scalable payments architecture, IXOPAY empowers businesses to streamline, secure, and increase the resilience of their payment systems. Learn more at www.ixopay.com.
About Aperia Compliance
Aperia Compliance, an IXOPAY company, is a leader in Payment Card Industry (PCI) validation and risk management, providing PCI Level 3 and 4 compliance for ISOs, payment processors, and small and medium-sized businesses. Learn more at www.aperia.com/proPCI - Aperiaducts/pci
Contact Information
Mills Forni
Verdis
mills@verdis.xyz
Related Images
|
Source: IXOPAY
View the original press release on accesswire.com
IXOPAY

Subscribe to releases from ACCESS Newswire
Subscribe to all the latest releases from ACCESS Newswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from ACCESS Newswire
PromiCell, Inc. presents during JP Morgan's 2026 Healthcare Conference9.1.2026 18:35:00 CET | Press release
MIAMI, FL / ACCESS Newswire / January 9, 2026 / PromiCell, Inc. (the "Company"), a clinical-stage cellular immunotherapy company uniquely positioned to advance potentially curative cell therapies for cancer patients, today announced that the Company's Chief Medical Officer, John Lee, MD, Ph.D., will present interim results of the Company's lead asset PRO CAR - 201A, a STEAP1 directed CAR T cell that is currently in the clinic as a first-in-human phase 1 trial for the treatment of metastatic castration-resistant prostate cancer (mCRPC), at Biotech Showcase 2026 in San Francisco, California on Monday, January 12, 2025 at 11:15 am PST at the Franciscan D (Ballroom Level). About PromiCell, Inc. PromiCell, is a clinical-stage cellular immunotherapy company with product candidates representing highly differentiated and novel CAR T and TCR T platforms to be developed across separate solid and hematologic types of cancer. Our pipeline of innovative products includes STEAP 1 CAR T cells, HA-1 T
Datavault AI Expands IBM Collaboration to Deploy Enterprise-Grade AI at the Edge with Available Infrastructure's SanQtum AI Platform8.1.2026 13:00:00 CET | Press release
Datavault AI will activate a secured multi-city edge AI network for real-time data tokenization, security, and monetization across New York and Philadelphia NEW YORK, NY / ACCESS Newswire / January 8, 2026 / Datavault AI Inc. (Nasdaq:DVLT), a leader in instant data monetization & enterprise digital twins, announced it will deliver enterprise-grade AI performance at the edge in New York and Philadelphia through an expanded collaboration with IBM using the SanQtum AI platform. Operated by Available Infrastructure, SanQtum AI is a fleet of synchronized micro edge data centers running IBM's watsonx portfolio of AI products on a zero-trust network. The combined deployment is designed to enable cybersecure data storage and compute, real-time data scoring, tokenization, and ultra-low-latency, across two of the most data-dense metro regions in the United States. By running Datavault AI's Information Data Exchange and DataScore agents - built with watsonx - within SanQtum AI's zero-trust edge e
Ascend Advanced Therapies - ABL Inc. Further Strengthens Executive Team as It Drives Forward an Ambitious Growth Strategy8.1.2026 13:00:00 CET | Press release
Seiga Ohmine to join as Chief Commercial Officer, Sharad Dubey as Chief Financial Officer and Patrick Lansky as Senior Vice President of Global Business Development Appointments underscore Ascend-ABL's commitment to scientific rigor, operational excellence, and strategic growth ROCKVILLE, MARYLAND / ACCESS Newswire / January 8, 2026 / Ascend Advanced Therapies - ABL Inc. today announced significant appointments to its leadership team. Seiga Ohmine Ph.D. joins as Chief Commercial Officer (CCO) Sharad Dubey CA, CPA joins as Chief Financial Officer (CFO) Patrick Lansky joins as Senior Vice President of Global Business Development These appointments reflect Ascend-ABL's focus on strengthening scientific leadership, operational discipline, and customer-centric execution as the company sharpens its positioning as a trusted CDMO partner for advanced viral modalities. Commenting on the appointments, Alessandra Rispoli, Chief Executive Officer of Ascend-ABL said, "We are making strong progress
Market Logic Announces Technology Partnership with Zappi to Accelerate Innovation with AI8.1.2026 08:00:00 CET | Press release
BERLIN, DE / ACCESS Newswire / January 8, 2026 / Market Logic Software is excited to announce a technology partnership with Zappi designed to help leading brands develop, refine, and test new product concepts faster than ever before. United by a joint agentic AI framework, this collaboration brings together advanced AI capabilities from both companies, marking a pivotal shift in how organizations execute insights-driven innovation. Through AI-to-AI integrations, linking two powerful AI platforms, enterprises can now enrich their product innovation process with a comprehensive data ecosystem. Specially trained DeepSights AI agents within Market Logic's Innovation Studio continuously monitor, analyse, and synthesize market research, news, and operational data-allowing for accelerated concept generation and more informed decision-making. With just a couple of clicks, customers can seamlessly progress to testing their concepts with real people, thanks to Zappi's real-world respondent solut
RE Royalties Announces up to a USD $9.0 Million Portfolio-Level Royalty Investment with Solaris Energy Inc.7.1.2026 22:20:00 CET | Press release
VANCOUVER, BC / ACCESS Newswire / January 7, 2026 / RE Royalties Ltd. (TSXV:RE)(OTCQX:RROYF) ("RE Royalties" or the "Company") is pleased to announce that it has entered into a definitive agreement with Solaris Energy Inc. ("Solaris") to invest up to USD $9.0 million to acquire a royalty interest (the "Royalty Purchase") in two portfolios of distributed generation ("DG") solar projects located throughout the United States. The first portfolio consists of 15 projects including 9 under construction with several nearing operation, and 6 in development, located across California, Maine, Delaware, New Hampshire and Colorado ("Portfolio 1"). The second portfolio comprises 9 more projects, the final composition of which may evolve as the projects advance ("Portfolio 2"). The transaction represents the acquisition of a portfolio level royalty on a diversified portfolio of DG solar assets and marks the exciting beginning of a new partnership between the two parties. The Royalty Purchase for Por
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom